Tirumalaraju, Divya. (2020) Pfizer Signs Multi-Year Deal to Manufacture Gilead's Remdesivir. Pharmaceutical Technology. Retrieved from  www.pharmaceutical-technology.com/news/pfizer-remdesivir-manufacturing/.

Pfizer signs multi-year deal to manufacture Gilead’s remdesivir


- Pfizer signs multi-year deal to manufacture Gilead’s remdesivir


Smith College

- Pharmaceutical Technology

- Medical News
- Science Daily
- Rapid Microbiology News
- Science Mission
- Pharmaceutical Microbiology
- ScienceAlert

References for treatment interventions of COVID-19 by news sites

News Articles from Pharmaceutical Technology about COVID-19 treatment interventions

• Selective statins may reduce SARS-CoV-2 cell entry and inhibit infection

News Articles from Medical News about COVID-19 treatment interventions

- Diagnostic Tool for Coronavirus Being Developed by University of Warwick

News Articles from Rapid Microbiology News about COVID-19 

- Long-lived antibodies in both blood and saliva of patients with COVID-19 detected
-The more contagious coronavirus variant may soon be the U.S.’s dominant strain

News Articles from Science Mission about COVID-19

News Articles from Pharmaceutical Microbiology about COVID-19

- Nitric Oxide may be a possible treatment for COVID-19 
- Statins reduce COVID-19 severity, most likely by removing cholesterol that 
   virus uses to infect
- Does the COVID-19 cytokine storm exist?
- Researchers identify nanobody that may prevent COVID-19 infection
- Strong activation of anti-bacterial T cells linked to severe COVID-19
- Mouthwashes, oral rinses may inactivate human coronaviruses, study finds
- Researchers identify three drugs as possible therapeutics for COVID-19

News Articles from Science Daily about COVID-19 

- 21 Existing Drugs Identified Appear to Block SARS-CoV-2 Replication in The Lab

Learn Before

Related

Learn After